ImClone Investigational Site

New Orleans, Louisiana 70121

0 studies enrolling now · 3 studies all time

What they study most

Adenocarcinoma, Colorectal Neoplasms, Gastric Cancer, Hepatocellular Carcinoma

Studies at this site

• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma — Completed
• A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib — Completed
• A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer — Completed